Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Collaboration brings together charity, university and pharmaceutical sectorsLandmark, launching today, is a three-year research partnership that aims ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Chardan's 8th Annual Genetic Medicines Conference on Monday, September 30, 2024.

More than 75% of the cohort started a TNF inhibitor during the selected time frame. For the rest, JAK inhibitors were the ...

One such Emirati woman is an award-winning strategic leader, Suhaila Ghubash, who's spent over 24 years transforming Dubai's ...

New Jersey’s workforce lost 4,400 jobs between July and August. The state lost 11,500 jobs between June and July, and 4,200 ...

For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the ...

Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

Reddy's, Jamieson Wellness, Merck, Novartis, Siemens Healthineers and Servier. Kinaxis' AI-powered software allows companies to orchestrate their supply chain network end to end, from strategic ...

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...